MCIC (MultiCorp International) FCF Margin %: 0.00% (As of Sep. 2023)


What is MultiCorp International FCF Margin %?

MultiCorp International MCIC FCF Margin % is 0.00% as of Sep. 2023.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. MultiCorp International's Free Cash Flow for the three months ended in Sep. 2023 was $0.00 Mil. MultiCorp International's Revenue for the three months ended in Sep. 2023 was $0.00 Mil. Therefore, MultiCorp International's FCF Margin % for the quarter that ended in Sep. 2023 was 0.00%.

As of today, MultiCorp International's current FCF Yield % is 0.00%.

The historical rank and industry rank for MultiCorp International's FCF Margin % or its related term are showing as below:


MCIC's FCF Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 2.445
* Ranked among companies with meaningful FCF Margin % only.

MultiCorp International FCF Margin % Related Terms

MultiCorp International FCF Margin % Historical Data

* Premium members only.

The historical data trend for MultiCorp International's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MultiCorp International FCF Margin % Chart

MultiCorp International Annual Data
Trend
FCF Margin %

MultiCorp International Quarterly Data
Jun21 Jun22 Sep22 Sep23
FCF Margin % 0.00 0.00 0.00 0.00

MCIC vs GPFT, KGKG, ERBB: FCF Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, MultiCorp International's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MultiCorp International FCF Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, MultiCorp International's FCF Margin % distribution charts can be found below:

* The bar in red indicates where MultiCorp International's FCF Margin % falls into.


MultiCorp International FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

MultiCorp International's FCF Margin for the fiscal year that ended in . 20 is calculated as

FCF Margin=Free Cash Flow (A: . 20 )/Revenue (A: . 20 )
=/
= %

MultiCorp International's FCF Margin for the quarter that ended in Sep. 2023 is calculated as

FCF Margin=Free Cash Flow (Q: Sep. 2023 )/Revenue (Q: Sep. 2023 )
=0/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
MultiCorp International (MCIC) has a FCF Margin % of 0.00% as of Sep. 2023. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on MultiCorp International and its competitors.
Is MultiCorp International's FCF Margin % too high?
MultiCorp International's current FCF Margin % is 0.00%.
How does MultiCorp International's FCF Margin % compare to GPFT and KGKG?
MultiCorp International's FCF Margin % of 0.00% can be compared against companies in the Drug Manufacturers industry. The industry median FCF Margin % is 2.45. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.45, based on 958 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on MultiCorp International and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MultiCorp International's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MultiCorp International stock overvalued right now?
MultiCorp International (MCIC) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For MultiCorp International (MCIC), the current FCF Margin % is 0.00% as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MultiCorp International Business Description

Address 5308 Derry Avenue, Suite R, Agoura Hills, CA, USA, 91301
MultiCorp International Inc buys and sells nitrile medically approved gloves and other PPE supplies to include gowns, masks and other items for the medical industry. The company is currently working on a medical app that will assist in monitoring potential life threatening scenarios.